Therefore, inhibition of exogeneous fatty acid uptake by targeting CD36 may synergize with inhibition of desaturation by targeting SCD (e.g., via small molecules CAY-10566 and TOFA39,40) in killing hypoxic cancer cells. Here, SCD is linked to cancer.